Mark Velleca is listed as a director on 2 SEC Form D filings by 1 issuer between Aug 2011 and Sep 2011: BioMarker Strategies LLC (Rockville, MD — biotechnology — 2011; $2.33M reported sold to 30 investors).
What this means One deal on file with the SEC, filed Sep 2011. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Christina Wyskiel (2 shared filings), Douglas Clark (2 shared filings), Glenn Miller (2 shared filings), Joseph Klein, III (2 shared filings), Paul Beresford (2 shared filings) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 court cases matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 7 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Mark Velleca and found 3 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Mark Velleca" (NC) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.